Hansoh Pharmaceutical Group Company Limited (HNSPF)
OTC
Closed
Oct 6, 2026
Day's Range
4.2552 wk Range
3.83Profile - HNSPF - Hansoh Pharmaceutical Group Company Limited
Profile
Mic Code
PINX
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
9.34K
Hansoh Pharmaceutical Group Company Limited undertakes the manufacturing and selling of pharmaceutical drugs primarily across China. As a leader in the Chinese pharmaceutical industry, Hansoh specializes in the research, development, production, and commercialization of therapeutic products targeting various complex conditions. The company's core focus includes oncology, central nervous system disorders, anti-viral treatments, and diabetes. Hansoh's innovative approach is reflected in its robust pipeline of patented drugs and its commitment to advancing public health. Operating from its well-established facilities, Hansoh Pharmaceutical is recognized for its substantial contribution to the healthcare sector, particularly in delivering high-quality and accessible medications. The company plays a pivotal role in addressing critical medical needs within one of the world's most populous regions. By prioritizing innovation and quality, Hansoh not only strengthens healthcare delivery in China but also enhances its capability to expand globally in the coming years. As the pharmaceutical industry continues to grow, Hansoh's strategic focus on research and development secures its position as a significant player in the market.
Profile Details
Type
Common Stock
Address
287 Xiangke Road
City
Shanghai
Zip
201210
Country
China
Phone
86 40 0828 5227
Key Executives - HNSPF - Hansoh Pharmaceutical Group Company Limited
Key executives
Cross Listings - HNSPF - Hansoh Pharmaceutical Group Company Limited
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
